BMPR1A
Reaktivität: Human
WB, ELISA, IHC, IF
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
ELISA 1: 1,000. Western blotting 1: 100 - 1: 500. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.25 mg/mL
Buffer
PBS with 0.09 % (W/V) sodium azide
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handhabung
Avoid repeated freezing and thawing.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Store the antibody at 2 - 8 °C up to one month or (in aliquots) at -20 °C for longer.
Target
BMPR1A
(Bone Morphogenetic Protein Receptor 1A (BMPR1A))
10q23del antikoerper, ACVRLK3 antikoerper, ALK3 antikoerper, CD292 antikoerper, SKR5 antikoerper, 1110037I22Rik antikoerper, AU045487 antikoerper, BMPR-IA antikoerper, Bmpr antikoerper, BMPR-1 antikoerper, BRK-1 antikoerper, BMPR1A antikoerper, acvrlk3 antikoerper, alk-3 antikoerper, alk3 antikoerper, cd292 antikoerper, skr5 antikoerper, BR1a antikoerper, alk3tr antikoerper, bmpr1a antikoerper, zgc:136731 antikoerper, wu:fe05b06 antikoerper, wu:fe06e10 antikoerper, zgc:92227 antikoerper, bone morphogenetic protein receptor type 1A antikoerper, bone morphogenetic protein receptor, type 1A antikoerper, bone morphogenetic protein receptor type 1A S homeolog antikoerper, bone morphogenetic protein receptor, type IAa antikoerper, bone morphogenetic protein receptor, type IAb antikoerper, BMPR1A antikoerper, Bmpr1a antikoerper, bmpr1a antikoerper, bmpr1a.S antikoerper, bmpr1aa antikoerper, bmpr1ab antikoerper
Hintergrund
The bone morphogenetic protein (BMP) receptors are a family of transmembrane serine/threonine kinases that include the type I receptors BMPR1A and BMPR1B and the type II receptor BMPR2. These receptors are also closely related to the activin receptors, ACVR1 and ACVR2. The ligands of these receptors are members of the TGF-beta superfamily. TGF-betas and activins transduce their signals through the formation of heteromeric complexes with 2 different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding. BMPRIA binds BMP4 with high-affinity in solution and is a potent BMP-4 antagonist in vitro. In adult tissues, BMPRIA is widely expressed, with the highest expression levels detected in skeletal muscle. BMPRIA is also widely expressed during embryogenesis.Synonyms: ACVRLK3, ALK-3, ALK3, Activin receptor-like kinase 3, Bone morphogenetic protein receptor type-1A, SKR5, Serine/threonine-protein kinase receptor R5